What Does Merus N.V. Do?

Total employees276
HeadquartersUtrecht
Founded

Merus N.V. is a clinical-stage immuno-oncology company dedicated to the discovery and development of innovative multispecific antibody therapeutics, known as Multiclonics®. These therapies are designed to harness the power of the immune system to treat cancer patients. Merus focuses on bispecific and trispecific antibodies that engage multiple targets simultaneously, aiming for improved efficacy and safety profiles compared to conventional treatments. Their proprietary Biclonics® and Triclonics® platforms enable the rapid generation and manufacturing of these complex molecules.

Where Is Merus N.V.'s Headquarters?

HQ Function

Global headquarters, housing primary research and development labs, corporate strategy, and administrative functions supporting Merus's worldwide operations.

Notable Features:

Strategically located in the Utrecht Science Park, a leading European hub for biomedical research and innovation, fostering collaboration and access to talent.

Work Culture:

Emphasizes scientific rigor, innovation, and collaboration. Employees are driven by a mission to develop life-changing therapies for cancer patients in a dynamic and research-focused setting.

HQ Significance:

Central to Merus's R&D capabilities, leveraging the strong life sciences ecosystem of Utrecht to advance its pipeline of bispecific and trispecific antibodies.

Values Reflected in HQ: Commitment to innovation, scientific excellence, patient impact, and collaboration, as evidenced by its location and focus on advanced therapeutic modalities.

Location:

Merus N.V. operates primarily from its headquarters in Utrecht, Netherlands, and its U.S. office in Watertown, Massachusetts. While its physical office presence is concentrated, its clinical trials and collaborations often have a global reach, involving sites and partners across North America, Europe, and Asia to advance its pipeline of cancer immunotherapies.

Street Address:

Padualaan 8

City:

Utrecht

State/Province:

Utrecht

Country:

Netherlands

Where Else Does Merus N.V. Operate Around the World?

Watertown, Massachusetts, USA

Address: 321 Arsenal Street, Suite 102, Watertown, MA 02472

To advance clinical trials, engage with regulatory bodies like the FDA, and build strategic partnerships within the U.S. biotechnology and pharmaceutical landscape.

Buying Intent Signals for Merus N.V.

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Merus N.V.? Meet the Executive Team

As of April 2025, Merus N.V.' leadership includes:

Bill Lundberg, M.D. - President, Chief Executive Officer
Björn van der Vlist - Chief Financial Officer
John A. Kober, J.D., M.I.P. - Chief Legal Officer and Corporate Secretary
Cecile Geuijen, Ph.D. - Chief Scientific Officer
Andrew Joe, M.D. - Chief Medical Officer
Ashley J.R. Buckle, Ph.D. - Chief Development Officer
Tim K. Prahl - Chief Operating Officer

Who's Investing in Merus N.V.?

Merus N.V. has been backed by several prominent investors over the years, including:

Entities affiliated with BVF Partners L.P.
Commodore Capital LP
Deep Track Capital, LP
Federated Hermes Kaufmann Small Cap Fund
Franklin Mutual Quest Fund

What Leadership Changes Has Merus N.V. Seen Recently?

Hire1
Exits1

Merus N.V. experienced key leadership changes in the past year, including the appointment of a new Chief Financial Officer and the departure of its Chief Business Officer, reflecting strategic adjustments in its executive team.

Departures

Sjaak J.L.M. van der Sar, Sjaak J.L.M. van der Sar's employment as Chief Business Officer concluded on March 31, 2024.

New Appointments:

Björn van der Vlist, Björn van der Vlist was appointed Chief Financial Officer, effective April 22, 2024, succeeding Bill Lundberg who served as interim Principal Financial Officer.

What Technology (Tech Stack) Is Used byMerus N.V.?

Discover the tools Merus N.V. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Merus N.V. Email Formats and Examples

Merus N.V. commonly uses the email format combining the employee's first name and last name, separated by a dot, followed by @merus.nl. Other variations might exist but this is a widely observed pattern.

[first].[last]@merus.nl

Format

jane.doe@merus.nl

Example

80%

Success rate

What's the Latest News About Merus N.V.?

Merus N.V. Press ReleaseMay 16, 2024

Merus N.V. Announces Publication in Nature Communications Highlighting Preclinical Data on MCLA-129 Program

Merus N.V. announced a publication in Nature Communications detailing preclinical data for MCLA-129, its bispecific antibody targeting EGFR and c-MET, demonstrating its potential in treating solid tumors, particularly non-small cell lung cancer (NSCLC)....more

Merus N.V. Press ReleaseMay 7, 2024

Merus N.V. Announces First Quarter 2024 Financial Results and Provides Business Update

Merus reported its financial results for Q1 2024, highlighting progress in its clinical pipeline, including updates on Zeno (zenocutuzumab), Petosemtamab, and MCLA-129, and reiterated its financial guidance for the year....more

Merus N.V. Press ReleaseApril 22, 2024

Merus N.V. Appoints Björn van der Vlist as Chief Financial Officer

Merus N.V. announced the appointment of Björn van der Vlist as Chief Financial Officer, effective April 22, 2024. Mr. van der Vlist brings over 20 years of experience in finance and leadership roles in the life sciences industry....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Merus N.V., are just a search away.